HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.

Abstract
Diabetic cardiomyopathy has been increasingly recognized as an important cause of heart failure in diabetic patients. Excessive oxidative stress has been suggested to play a critical role in the development of diabetic cardiomyopathy. The objective of this study was to investigate the potential protective effects and mechanisms of taxifolin on cardiac function of streptozotocin-induced diabetic mice and on hyperglycemia-induced apoptosis of H9c2 cardiac myoblasts. In vivo study revealed that taxifolin improved diastolic dysfunction, ameliorated myocardium structure abnormality, inhibited myocyte apoptosis and enhanced endogenous antioxidant enzymes activities. Interestingly, taxifolin reduced angiotensin II level in myocardium, inhibited NADPH oxidase activity, and increased JAK/STAT3 activation. In vitro investigation demonstrated that taxifolin inhibited 33 mM glucoseinduced H9c2 cells apoptosis by decreasing intracellular ROS level. It also inhibited caspase-3 and caspase-9 activation, restored mitochondrial membrane potential, and regulated the expression of proteins related to the intrinsic pathway of apoptosis, thus inhibiting the release of cytochrome c from mitochondria into the cytoplasm. In conclusion, taxifolin exerted cardioprotective effects against diabetic cardiomyopathy by inhibiting oxidative stress and cardiac myocyte apoptosis and might be a potential agent in the treatment of diabetic cardiomyopathy.
AuthorsXiao Sun, Rong-chang Chen, Zhi-hong Yang, Gui-bo Sun, Min Wang, Xiao-jun Ma, Li-juan Yang, Xiao-bo Sun
JournalFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association (Food Chem Toxicol) Vol. 63 Pg. 221-32 (Jan 2014) ISSN: 1873-6351 [Electronic] England
PMID24269735 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Reactive Oxygen Species
  • Angiotensin II
  • Streptozocin
  • Quercetin
  • taxifolin
  • NADPH Oxidases
  • Caspases
Topics
  • Angiotensin II (blood)
  • Animals
  • Apoptosis (drug effects)
  • Caspases (metabolism)
  • Cell Line
  • Diabetes Mellitus, Experimental (complications)
  • Diabetic Cardiomyopathies (prevention & control)
  • Enzyme-Linked Immunosorbent Assay
  • In Situ Nick-End Labeling
  • In Vitro Techniques
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NADPH Oxidases (metabolism)
  • Oxidative Stress (drug effects)
  • Quercetin (analogs & derivatives, pharmacology)
  • Rats
  • Reactive Oxygen Species (metabolism)
  • Streptozocin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: